Pediatric inflammatory diseases. Part I: multiple sclerosis

Neuroradiology Journal

Volumn 25, Issue 6, 2012, Pages 684-694

  Catalucci, A ^a   Anselmi, M ^a   Splendiani, A ^a   Smith, J D ^b   Limbucci, N ^c   Giangaspero, F ^d   Gallucci, Massimo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b DREXEL UNIVERSITY   (United States)

^c CAREGGI UNIVERSITY HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Giant plaques; MRI; Pediatric multiple sclerosis (PMS)

Indexed keywords

HLA DQ ANTIGEN; HLA DQ6 ANTIGEN; HLA DR15 ANTIGEN; UNCLASSIFIED DRUG;

CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; DISEASE COURSE; DISEASE SEVERITY; FOLLOW UP; HUMAN; IMMUNE RESPONSE; INTRACRANIAL HYPERTENSION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NERVE CELL PLASTICITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OPTIC NEURITIS; PROGNOSIS; REVIEW; SCHILDER DISEASE;

EID: 84872738249     PISSN: 19714009     EISSN: None     Source Type: Journal    
DOI: 10.1177/197140091202500608     Document Type: Review

References (25)

1. Krupp LB, Banwell B, Tenembaum S. Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology. 2007; 68 (Suppl 2): S7-S12.
2. Gallucci M, Caulo M, Cerone G, et al. Acquired inflammatory white matter diseases. Child's Nerv Syst. 2001; 17: 202-210.
3. Duquette P, Murray TJ, Pleines J. MS in childhood: clinical profile in 125 patients. J Pediatr. 1987; 111: 359-363.
4. Gallucci M, Gagliardo O, Splendiani A, et al. Malattie demielinizzanti infantili (italian). Rivista di Neuroradiologia. 1999; 12: 97-102.
5. Shaw CM, Alword Ecjr. MS beginning in infancy. J Child Neurol. 1987; 2: 252-256.
6. Ness JM, Chabas D, Sadovnick AD, et al. Clinical features of children and adolescents with multiple sclerosis. Neurology. 2007; 68 (Suppl 2): S37-S45.
7. Mikaeloff Y, Adamsbaum C, Husson B, et al. MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain. 2004; 127: 1942-1947.
8. Zelnik N, Gale AD, Shelburne SA jr. Multiple sclerosis in black children. J Child Neurol. 1991; 6: 53-57.
9. Micheli C, Bozzao A, et al. Multiple sclerosis in the pediatric age and Schilder disease (abs). Neuroradiology. 1996: S56.
10. Simone IL, Carrara D, Tortorella C, et al. Course and prognosis in early-onset MS: comparison with adultonset forms. Neurology. 2002; 59: 1922-1928.
11. Miller DH, Barkhof F, Montalban X, et al. Clinically isolated syndromes suggestive of multiple sclerosis, part 1: natural history, pathogenesis, diagnosis and prognosis. Lancet Neurol. 2005; 4: 281-288.
12. Optic neuritis study group. The 5-year risk of MS after optic neuritis. Experience of the optic neuritis treatment trial. Neurology. 1997; 49: 1404-1413.
13. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann. Neurol. 2001; 50: 121-127.
14. Jeffery AR, Buncic JR. Pediatric Devic's neromyelitis optica. J Pediatr Ophthalmol Strabismus. 1996; 33:
15. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol. 2005; 58: 840-846.
16. Barkhof F, Filippi M, Miller DH, et al. Comparison of MR imaging criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997; 120: 2059-2069.
17. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. Am J Neuroradiol. 2000; 21: 702-706.
18. Hahn CD, Shroff MM, Blaser SI, et al. MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology. 2004; 62: 806-808.
19. McAdam LC, Blaser SI, Banwell BL. Pediatric tumefactive demyelination: case series and review of the literature. Pediatr Neurol. 2002; 26: 18-25.
20. Cha S, Pierce S, et al. Dynamic contrast-enhanced T2*-w MRI of Tumefactive Demyelinating Lesions. Am J Neuroradiol. 2001; 22: 1109-1116.
21. Malhotra HS, Jain KK, et al. Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy. Mult Scler. 2009; 15 (2): 193-203.
22. Filippi M, Bozzali M, Rovaris M, et al. Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. Brain. 2003; 126: 433-437.
23. Bruhn H, Frahm J, Merboldt KD, et al. Multiple sclerosis in children: cerebral metabolic alterations monitored by localized proton magnetic resonance spectroscopy in vivo. Ann Neurol. 1992; 32: 140-150.
24. Mezzapesa DM, Rocca MA, Falini A, et al. A preliminary diffusion tensor and magnetization transfer magnetic resonance imaging study of early-onset multiple sclerosis. Arch Neurol. 2004; 61: 366-368.
25. Eisele P, Szabo K, et al. Reduced diffusion in a subset of Acute MS lesions: a serial multiparametric MRI study. Am J Neuroradiol. 2012; 33: 1369-73.